Tepotinib Plus Paclitaxel in MET Amplified or MET Exon 14 Alterated Gastric and GEJ Carcinoma
Clinical trial NCT05439993 · UNKNOWN
Trial details
- NCT number
- NCT05439993
- Sponsor
- Hallym University Medical Center
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2026-06-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.